Classical rheumatoid arthritis is characterised histologically by the presence of rheumatoid granulomata which can be regarded as a manifestation of a cellmediated immune response directed against an, as yet unknown, antigen. Previously published observations on cell-mediated immunity in rheumatoid arthritis are conflicting (Menard et al., 1973; Waxman et al., 1973; Lance and Knight, 1974; Messner, 1974; Sheldon et al., 1974; Hepburn et al., 1976 (Menard et al., 1973 of 3H thymidine was added to the cultures (concentration 20 ,uCi/ml, specific activity 40 mCi/mmol). Viability of cultures was routinely determined before harvesting which was performed using a multisample semi-automated harvester (Skatron, Lierbyen, Norway).
Cultures of unstimulated cells from the same patient were made at all times in order to determine the rate of spontaneous transformation. Maximal stimulation responses were obtained by selecting optimum doses of both mitogens and antigens by preparing dose response curves. Doses of antigens and mitogens were tested in the following ranges: PHA (Difco Laboratories, Detroit, Michigan, USA) 0-100 jig/ml-mean optimum dose 14 jg/ml; PWM 0-50 jig/ml-mean optimum dose 25 jg/ml; Candida antigen (Hollister Stier Laboratories, Missisauga, Ontario, Canada) 0-1:5000 dilution stock solution-mean optimum dosage 1:2000, The HSV1 antigen was prepared by treatment of an infected monkey cell culture (Vero) with 0. 3 % propiolactone (Russell, 1974) .
After harvesting, the fibre discs were removed, placed-in 10 ml of scintillation fluid and the emissions counted in a Beckman L.S. 230 scintillation counter.
Results were expressed as the long of the ratio be.
tweeti stimulated and unstimulated cells from the same subject.
Statistics
The significance of lymphocyte responsiveness-to mitogens and antigens comparing normals against pretreatment rheumatoid patients, normals versus post-treatment rheumatoid patients, and rheumatoid patients pretreatment versus post-treatment was calculated using sample tests of proportions. The relationship between laboratory variables to clinical status was tested using binomial distribution tables with a probability of success of 0.5.
Results

SPONTANEOUS TRANSFORMATION
A wide range of spontaneous transformations was seen in patients with rheumatoid arthritis and in normal controls. No statistically significant difference was detected between the results obtained in both groups.
LYMPHOCYTE RESPONSIVENESS TO MITOGENS
The PHA responses of lymphocytes in patients with rheumatoid arthritis was significantly less than the PHA response in the 30 normal control subjects (Fig. 1) . Only 2 normal subjects had a logl0 transformation index of less than 1. Seventeen pati0nts with rheumatoid arthritis had a depressed response randomly selected patients with RA compared to 30 normal controls (P<001). Follow up data were available after 6 months' treatment with either gold or penicillamine in 33 patients and there was a trend towards normalisation of the responses in patients with rheumatoid arthritis. At this time only 5 of 33 patients had a depressed PHA response. There was a statistically significant difference (P <0.05) between PHA responses seen in patients before treatment and after treatment (Fig. 2) . There was no significant difference between PHA responses in the normal group and in the 33 patients seen with rheumatoid arthritis at follow up. Patients with rheumatoid arthritis had lymphocyte transformation responses to PWM which were significantly elevated (P<0.001) over those levels seen in normal control subjects (Fig. 3) . At follow up there had been a normalisation of the PWM response in the 32 patients studied which was significantly different (P <0.001) from pretreatment results (Fig. 4) . There was no statistically significant difference between PWM response of the normal control population and the 32 patients seen with rheumatoid arthritis at follow up. Successful treatment of rheumatoid arthritis tended to enhance in vitro lymphocyte responsiveness to PHA whereas the response to PWM was reduced.
LYMPHOCYTE RESPONSES TO ANTIGENS
Lymphocyte responses to HSV1 and Candida antigens in patients with rheumatoid arthritis were reduced when compared with normal controls (P<0-05). At follow up the 31 patients seen after 6 months' treatment with gold or penicillamine demonstrated an increase in the lymphocyte responsiveness to these 2 antigens and a significant difference (P < 001) existed between responses before and after treatment. A striking feature was that the post treatment response to Candida and HSV1 was enhanced when compared to the normal control group.
RELATIONSHIP BETWEEN CLINICAL IMPROVEMENT AND IMPROVEMENT IN LABORATORY VARIABLES
Of the 61 patients with rheumatoid arthritis seen initially, 32 patients were available for follow up after 6 months' treatment with either gold or penicillamine therapy. At this time 19 patients had shown clinical improvement and 13 remained unchanged. Of the 12 clinically improved patients whose initial response to PHA was depressed 11 showed improvement to normal levels at follow up (Fig. 5 ). This Fig. 4 Changes in PWM responses in 32 patients with RA, initially and at 6 month follow up correlation is significant (P<0 05). In contrast, in the clinically unchanged group improvement in PHA response occurred in 2 out of the 3 patients in whom it had been suppressed (Fig. 6) . Similar changes were seen in response to Candida and HSV1 antigens (P<0.05). The PWM response tended to decline to normal levels with clinical improvement (P<0 .05).
Discussion
The results of our study support those previously published which suggest that in vitro lymphocyte responsiveness to both mitogens and antigens is abnormal in patients with rheumatoid arthritis (Menard et al., 1973; Waxman et al., 1973; Lane and Knight, 1974; Messner, 1974; Sheldon et al., 1974; Hepburn et al., 1976 (Menard et al., 1973) . Any group of patients suffering from rheumatoid arthritis will show a great range of disease activity and this may indeed account for some of the apparent discrepancies between previous reports of studies of lymphocyte function in rheumatoid arthritis. Our initial group of patients consisted of 61 patients taken at random from our clinics. Although this group contained patients who had been on long-term management for their disease and were in clinical remission, an attempt was made to include in this group all patients with newly diagnosed rheumatoid arthritis before institution of therapy other than routine anti-inflammatory drugs. Thus a considerable number of patients in our study had active disease at the time of their initial evaluation. At follow up every attempt was made to include patients who had previously been seen with active disease and in the interim period had received treatment with either gold or penicillamine. Included lymphocyte function which is independent of their effects on rheumatoid disease activity exists. We have been unable to produce any in vitro evidence of this although Harth et al. (1976) has been able to demonstrate an apparent suppression of lymphocyte response to PHA after incubation with gold salts in vitro.
The interpretation of the in vitro responsiveness of lymphocytes to PWM and other antigens in man is the subject of some debate. The PHA response appears to be largely a reflection of T-cell function. PWM may also be an indicator of B-cell activity. T cells are probably primarily responsible for the reaction to Candida and HSV1 antigens. If this interpretation is applied to our data, the results are fully congruous in that restoration of T-cell function as reflected by improvement in PHA response is associated with a return towards normal of the PWM response. Improvement in T-cell function could also be held to account for the increase in magnitude of the response to HSV1 and Candida antigens.
Our study would suggest that patients with active rheumatoid arthritis do have significantly impaired lymphocyte responses as tested in in vitro methods and that this abnormality is directly related to clinical disease state. These abnormal responses appear to be reversible and after 6 months' follow up in a longitudinal study we have been able to demonstrate an improvement in T-cell function which is associated with clinical improvement to the extent that patients with inactive rheumatoid arthritis had responses indistinguishable from those seen in normal controls. 
